Literature DB >> 28540972

Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Michał Lipiński, Grażyna Rydzewska1, Wanda Foltyn, Elżbieta Andrysiak-Mamos, Agata Bałdys-Waligórska, Tomasz Bednarczuk, Jolanta Blicharz-Dorniak, Marek Bolanowski, Agnieszka Boratyn-Nowicka, Małgorzata Borowska, Andrzej Cichocki, Jarosław B Ćwikła, Massimo Falconi, Daria Handkiewicz-Junak, Alicja Hubalewska-Dydejczyk, Barbara Jarząb, Roman Junik, Dariusz Kajdaniuk, Grzegorz Kamiński, Agnieszka Kolasińska-Ćwikła, Aldona Kowalska, Robert Król, Leszek Królicki, Jolanta Kunikowska, Katarzyna Kuśnierz, Paweł Lampe, Dariusz Lange, Anna Lewczuk-Myślicka, Andrzej Lewiński, Magdalena Londzin-Olesik, Bogdan Marek, Anna Nasierowska-Guttmejer, Ewa Nowakowska-Duława, Joanna Pilch-Kowalczyk, Karolina Poczkaj, Violetta Rosiek, Marek Ruchała, Lucyna Siemińska, Anna Sowa-Staszczak, Teresa Starzyńska, Katarzyna Steinhof-Radwańska, Janusz Strzelczyk, Krzysztof Sworczak, Anhelli Syrenicz, Andrzej Szawłowski, Marek Szczepkowski, Ewa Wachuła, Wojciech Zajęcki, Anna Zemczak, Wojciech Zgliczyński, Beata Kos-Kudła.   

Abstract

This paper presents the updated Polish Neuroendocrine Tumour Network expert panel recommendations on the management of neuroendocrine neoplasms (NENs) of the stomach and duodenum, including gastrinoma. The recommendations discuss the epidemiology, pathogenesis, and clinical presentation of these tumours as well as their diagnosis, including biochemical, histopathological, and localisation diagnoses. The principles of treatment are discussed, including endoscopic, surgical, pharmacological, and radionuclide treatments. Finally, there are also recommendations on patient monitoring.

Entities:  

Keywords:  diagnostics; duodenum; gastrinoma; guidelines; neuroendocrine neoplasms; stomach; therapy

Mesh:

Year:  2017        PMID: 28540972     DOI: 10.5603/EP.2017.0016

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  8 in total

1.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

2.  The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database.

Authors:  Peng Wang; Erlin Chen; Mingjie Xie; Wei Xu; Chaoyang Ou; Zhou Zhou; Yuanjie Niu; Wei Song; Qingfeng Ni; Jianwei Zhu
Journal:  J Gastrointest Surg       Date:  2022-06-10       Impact factor: 3.267

3.  Endoscopic mucosal resection using a ligation device for duodenal neuroendocrine tumors: a simple method.

Authors:  Yasuhiro Inokuchi; Kei Hayashi; Yoshihiro Kaneta; Yoichiro Okubo; Mamoru Watanabe; Mitsuhiro Furuta; Nozomu Machida; Shin Maeda
Journal:  Ther Adv Gastrointest Endosc       Date:  2022-06-09

4.  Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.

Authors:  R E Rossi; A C Milanetto; V Andreasi; D Campana; J Coppa; G Nappo; M Rinzivillo; P Invernizzi; R Modica; A David; S Partelli; G Lamberti; V Mazzaferro; A Zerbi; F Panzuto; C Pasquali; M Falconi; S Massironi
Journal:  J Endocrinol Invest       Date:  2021-03-02       Impact factor: 4.256

5.  NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.

Authors:  Anna Malczewska; Kjell Oberg; Beata Kos-Kudla
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

6.  The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.

Authors:  A Malczewska; A Procner; A Walter; K Kusnierz; W Zajecki; H Aslanian; B Kos-Kudla
Journal:  BMC Gastroenterol       Date:  2020-07-23       Impact factor: 3.067

7.  Short- and long-term outcomes of endoscopic submucosal dissection for non-ampullary duodenal neuroendocrine tumors.

Authors:  Masafumi Nishio; Kingo Hirasawa; Yuichiro Ozeki; Atsushi Sawada; Ryosuke Ikeda; Takehide Fukuchi; Ryosuke Kobayashi; Makomo Makazu; Chiko Sato; Shin Maeda
Journal:  Ann Gastroenterol       Date:  2020-04-13

8.  Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.

Authors:  Yu-Jie Zhou; Qi-Wen Wang; Qing-Wei Zhang; Jin-Nan Chen; Xin-Yuan Wang; Yun-Jie Gao; Xiao-Bo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.